Sichuan, China

Yan Qing

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Sichuan Keiun-Biotech Biopharmaceutical Co., Ltd., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Qing. Retrieved from https://idiyas.com/inventor/yan-qing-82d5so0h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 16.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Yan Qing: Revolutionizing Technology in Sichuan

Introduction: Yan Qing is a pioneering inventor hailing from Sichuan, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Yan Qing holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Yan Qing has worked with prestigious research institutions and leading tech companies, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout her career, Yan Qing has collaborated with top universities and multinational corporations, fostering a culture of innovation and knowledge-sharing in the tech industry.

Conclusion: Yan Qing's relentless pursuit of innovation and her significant contributions to technology make her a trailblazer in the field of inventions, inspiring future generations of inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…